Mill Capital Management’s Pfizer PFE Stock Holding History

Mill Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.32M	Sell	153,865 -4,400	-3%	-$117K	0.33%	43
2025 Q4	$3.94M	Hold	158,265	–	–	0.28%	43
2025 Q3	$4.03M	Sell	158,265 -12,637	-7%	-$312K	0.3%	44
2025 Q2	$4.14M	Sell	170,902 -5,350	-3%	-$125K	0.32%	40
2025 Q1	$4.47M	Sell	176,252 -8,653	-5%	-$226K	0.36%	39
2024 Q4	$4.91M	Sell	184,905 -5,259	-3%	-$143K	0.39%	38
2024 Q3	$5.5M	Sell	190,164 -5,127	-3%	-$150K	0.43%	37
2024 Q2	$5.46M	Sell	195,291 -7,679	-4%	-$211K	0.45%	38
2024 Q1	$5.63M	Sell	202,970 -2,000	-1%	-$55.5K	0.47%	38
2023 Q4	$5.9M	Sell	204,970 -3,576	-2%	-$108K	0.53%	38
2023 Q3	$6.92M	Sell	208,546 -953	-0.5%	-$33.7K	0.68%	37
2023 Q2	$7.68M	Buy	209,499 +7,277	+4%	+$283K	0.72%	37
2023 Q1	$8.25M	Sell	202,222 -8,915	-4%	-$385K	0.84%	34
2022 Q4	$10.8M	Hold	211,137	–	–	1.19%	30
2022 Q3	$9.24M	Sell	211,137 -303	-0.1%	-$14.7K	1.08%	27
2022 Q2	$11.1M	Hold	211,440	–	–	1.23%	27
2022 Q1	$10.9M	Sell	211,440 -2,340	-1%	-$121K	1.05%	32
2021 Q4	$12.6M	Buy	+213,780	New	+$10.6M	1.29%	23

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Mill Capital Management's PFE Position: Q1 2026 in Review

Mill Capital Management reduced its Pfizer (PFE) stake by 2.8% in Q1 2026, selling an estimated $117K and leaving 153,865 shares worth $4.32M. The position accounts for 0.33% of the portfolio, ranked #43.

Mill Capital Management first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $12.6M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Mill Capital Management held 153,865 shares of Pfizer worth $4.32M as of Q1 2026.
Mill Capital Management sold 4,400 Pfizer shares in Q1 2026, an estimated $117K.
Pfizer made up 0.33% of Mill Capital Management's portfolio in Q1 2026, its #43 holding.
Mill Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
Mill Capital Management's Pfizer position peaked at $12.6M in Q4 2021.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mill Capital Management's 13F filing for Q1 2026, filed 4 May 2026.